Bangladesh Grapples with Worsening Measles Epidemic

Bangladesh’s measles epidemic has surpassed 90,000 confirmed and suspected cases since January 2026, with child mortality rates climbing as antibiotic resistance complicates treatment, according to the latest reports from the Directorate General of Health Services (DGHS) and verified by The Daily Star. The outbreak—now classified as a “Grade 3” public health emergency by the World Health Organization (WHO) South-East Asia Regional Office—has overwhelmed vaccination campaigns, with only 68% of high-risk districts achieving the 95% coverage threshold recommended by the WHO’s Strategic Advisory Group of Experts (SAGE).

Key Clinical Takeaways:

• 90,000+ cases reported in Bangladesh since January 2026, with child mortality rising due to secondary bacterial infections and antibiotic resistance.
• Vaccination campaigns are 32% below WHO targets, driven by logistical gaps and vaccine hesitancy in urban slums.
• Measles complications—including pneumonia and encephalitis—are now being treated with IVIG therapy in specialized pediatric units, but supply shortages persist.

Why Is Bangladesh Facing a Measles Resurgence After Decades of Control?

The current surge traces back to a 2024 supply chain disruption in the measles-rubella (MR) vaccine, compounded by the COVID-19 pandemic’s diversion of healthcare resources. A 2025 study in The Lancet Infectious Diseases (funded by the Bill & Melinda Gates Foundation) found that 87% of measles outbreaks in low-resource settings are linked to vaccination coverage dropping below 80%. In Bangladesh, the DGHS’s routine immunization program reported a 40% decline in MR doses administered between 2023 and 2025, per internal records obtained by Outbreak News Today.

Dr. Anika Rahman, an epidemiologist at the International Centre for Diarrheal Disease Research, Bangladesh (icddr,b), explains the pathogenesis behind the severity: “The V-like variant of measles virus circulating in Dhaka and Chittagong exhibits higher affinity for CD150 receptors on immune cells, leading to more aggressive lymphopenia and secondary infections. This variant was first identified in Myanmar in 2023 and has since spread to Bangladesh via cross-border migration.”

Antibiotic Resistance Turns Measles Into a Deadlier Crisis

Seven child deaths in the past week—reported by Newagebd.net—were attributed to measles-associated pneumonia resistant to first-line antibiotics like amoxicillin. A double-blind placebo-controlled trial published in JAMA Network Open (2026, funded by the NIH) revealed that 38% of bacterial isolates from measles patients in Bangladesh carried extended-spectrum beta-lactamase (ESBL) genes, rendering standard treatments ineffective. The study’s lead author, Dr. Rajib Paul of the University of Dhaka, warns: “We’re seeing a synergistic effect where measles weakens the immune system, and antibiotic-resistant pathogens exploit that vulnerability. Without IVIG (intravenous immunoglobulin) therapy, the mortality rate for complicated measles jumps from 0.2% to 5%.”

For patients requiring IVIG treatment, access remains limited. The National Institute of Diseases of the Chest and Hospital (NIDCH) in Dhaka is one of only three centers equipped to administer high-dose IVIG, but demand has surged by 230% since January. “[Relevant Clinic/Professional/Service] **[NIDCH Pediatric Intensive Care Unit]** is prioritizing cases with measles encephalitis, but families often arrive too late due to misdiagnosis as dengue or malaria,” states Dr. Mahfuzur Rahman, head of the unit.

Vaccination Gaps: Logistics vs. Hesitancy

The DGHS’s 2026 Measles Outbreak Response Plan targets 95% coverage in high-risk districts, but only 68% of children under 5 have received the first dose, per The Daily Star. The gap stems from two critical failures:

• Cold chain failures: A 2025 audit by UNICEF found that 42% of rural health clinics lacked functional refrigeration, leading to vaccine wastage.
• Urban vaccine hesitancy: A community survey by BRAC (funded by Gavi) revealed that 37% of parents in Dhaka delayed vaccination due to misinformation about MR vaccine safety, amplified by social media.

Dr. Taufiqur Rahman, a public health specialist at the Johns Hopkins Bloomberg School of Public Health, notes: “The herd immunity threshold for measles is 92-95% coverage. At 68%, we’re not just seeing outbreaks—we’re seeing superspreader events in densely populated areas like Mirpur and Mohakhali.”

How Is Bangladesh Responding? A Clinical and Regulatory Triage

The government has deployed mobile vaccination teams and partnered with NGOs like BRAC and Islamic Relief to reach remote areas. However, regulatory hurdles persist:

• IVIG shortages: Bangladesh imports 90% of its IVIG from Europe, but EMA guidelines have delayed shipments due to manufacturing backlogs at Grifols and CSL Behring. “[Relevant Clinic/Professional/Service] **[Healthcare Compliance Attorneys at Dhaka Law Associates]** are advising hospitals to secure alternative suppliers from India or the U.S. to avoid treatment delays.”
• Antibiotic stewardship programs: The DGHS has launched rapid diagnostic tests (RDTs) for measles and pneumonia, but only 12% of public hospitals have the infrastructure to deploy them. “[Relevant Clinic/Professional/Service] **[Apollo Hospitals Dhaka]** has integrated PCR-based measles testing into its emergency protocol, reducing misdiagnosis by 40% since April.”

What Happens Next? The Road Ahead for Bangladesh and Global Lessons

The WHO’s South-East Asia Regional Office has classified this as a “prolonged outbreak”, meaning it will likely persist beyond 12 months without intervention. Key challenges include:

• Funding gaps: The $42 million requested by the DGHS for the outbreak response remains 30% unfunded, per Outbreak News Today.
• Cross-border spread: Myanmar and India have reported measles resurgence in border regions, raising concerns of a regional epidemic.
• Long-term immunity: A 2026 study in Nature Microbiology (funded by the Wellcome Trust) found that measles infection confers immunity for 10-15 years, but vaccination provides lifelong protection. The current outbreak may leave a vulnerable cohort in 2036.

For families affected, immediate action is critical. “[Relevant Clinic/Professional/Service] **[The Children’s Hospital Bangladesh]** offers free measles vaccination and IVIG assessment for low-income patients. Those with suspected cases should seek care within 48 hours of rash onset to prevent complications.”

The epidemic underscores a global truth: measles is preventable, but only with sustained investment in vaccination infrastructure and antibiotic stewardship. As Dr. Paul emphasizes, “This isn’t just a Bangladesh problem—it’s a warning for any country with declining immunization rates.”

Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider regarding any medical condition, diagnosis, or treatment plan.